Women are counselled that surgery for ulcerative colitis leads to infertility and that they could require assisted reproductive technology (ART) to conceive. But how successful is ART, compared with ...

ROCHESTER, Minn -- A new study led by Mayo Clinic researchers has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab, according to ...

If you have ulcerative colitis, your doctor may suggest surgery as the key to improving your quality of life. There are plenty of solid reasons for getting an operation, but it's OK to ask another ...

It’s become common for people to get ulcerative colitis surgery in the early stages of the disease. But whether you’re in the early or late stages or somewhere in between, you’re likely wondering how ...

Approximately 15% of patients with ulcerative colitis develop an acute attack of severe colitis, and 30% of these patients require colectomy. Severe ulcerative colitis is therefore considered a ...

A new study has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab. A new study led by Mayo Clinic researchers has found that ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

"Due to the timing of diagnosis during this critical period of physical, intellectual, and psychosocial development, the higher rate of colectomy, and their longer lifespan without a colon, it is ...

Philadelphia, Pa. (October 10, 2013) –"Pouchitis" developing after surgery for ulcerative colitis (UC) is associated with changes in gene expression, which increase along with disease severity, ...

Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...

As the vice chairman of surgery at Mount Sinai, Harris specializes in treating Crohn’s disease and ulcerative colitis. A 22-year veteran, he sees 200-300 patients with ulcerative colitis every year.